United Therapeutics Stock
United Therapeutics Stock
The price for the United Therapeutics stock decreased slightly today. Compared to yesterday there is a change of -€0.900 (-0.210%).
With 27 Buy predictions and 1 Sell predictions United Therapeutics is one of the favorites of our community.
With a target price of 541 € there is a positive potential of 25.2% for United Therapeutics compared to the current price of 432.1 €.
So far the community has only identified positive things for United Therapeutics stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of United Therapeutics in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | -0.210% | -7.275% | -6.269% | 61.171% | 1.123% | 98.850% | 151.221% |
| Ionis Pharmaceuticals Inc. | 0.930% | 1.290% | 2.869% | 34.457% | -27.192% | 35.265% | 46.999% |
| Ligand Pharmaceuticals | -0.800% | 0.787% | -5.882% | 93.939% | 54.217% | 306.349% | 173.329% |
| Novocure Ltd | 1.630% | 12.459% | 7.105% | 54.110% | 34.980% | -46.410% | -87.045% |
Comments
United Therapeutics (UTHR) had its price target lowered by Royal Bank Of Canada from $704.00 to $677.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by JPMorgan Chase & Co. from $685.00 to $687.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat